Source: EUROMEDSTAT (http://www.euromedstat.cnr.it/reports/reports_reimbursement_categories.asp)
AUSTRIA
"Heilmittelverzeichnis": Pharmaceuticals listed on the "Heilmittelverzeichnis" (Pharmaceutical List) qualify for automatic reimbursement (100%)
Continue Reading
Written by James Love
Thursday, 20 March 2008
On March 20, 2008, KEI published "Selected Innovation Prizes and Reward Programs" (cite as KEI Research Note 2008:1). The paper, which is available on the Internet here: https://www.keionline.org/misc-docs/research_notes/kei_rn_2008_1.pdf, provides the most comprehensive account of historical uses of prizes to induce innovation now available. The introduction to the 51 page report follows:
Written by James Love
Tuesday, 23 October 2007
The following are comments by experts on innovation and public health, beginning with consumer and public health groups, followed by academic experts and others.
This document has been replaced with a much longer paper: KEI Research Note 2008:1
PROMINENT INNOVATION PRIZES AND REWARD PROGRAMS
KEI Research Note 2007:X*
November 4, 2007
Written by Judit Rius Sanjuan
Wednesday, 23 May 2007
Informe de KEI
Written by James Love Continue Reading
November 5-10, 2007
KEI Documents
November 9, 2007. Malini Aisola. Reasons Why the IGWG Should Not Place Limits on the Scope of Disease.
Thiru Balasubramaniam, Geneva Representative, Knowledge Ecology International
Sara Crager, MD/PhD Candidate '12 at Yale University/Universities Allied for Essential Medicines
Nicoletta Dentico, Policy and Advocacy Advisor, DNDi
Tuesday, 05 June 2007
An pdf version of this document is available here.
David Serafino[1]
Knowledge Ecology International
4 June 2007
Table of Contents
Saturday, 02 June 2007
The Essential Medical Inventions Licensing Agency
Working Plan, June 1, 2007
Introduction